View in Other Languages
   


Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) is pleased to announce another contract award to deliver an MABR-based Aspiral(TM) smart packaged solution in China. This latest contract win is for a 200 m3/day wastewater treatment plant for a highway service area in Xiaogan, Hubei Province, in China. The project calls for two (2) Aspiral(TM) L4 units to be commissioned and operational by August 2018. This MABR-based installation is Fluence's second in Hubei Province, following successful commissioning of the first in June 2017.

- Sale is the first under the framework agreement with new local Chinese partner Hubei ITEST

- Following successful testing, further opportunities exist for other highway service areas

- Aspiral(TM) sales momentum continues to grow across multiple provinces in China

This is the first contract secured under a framework agreement with Fluence's new local Chinese partner Hubei Communication Investment Intelligent Detection Co., Ltd. (Hubei ITEST). According to the terms of the agreement, following successful testing of this plant, the sale is expected to pave the way for additional Aspiral(TM) sales in the remaining service areas along the highways in Hubei Province, for which Hubei ITEST is responsible. Fluence is able to meet demand for rigorous timelines for China's wastewater requirements due to its pre-engineered smart packaged systems, which are locally produced in China.

Regarding this sale and cooperation, Ms. Hui Du, Managing Director of Hubei ITEST stated: "We are pleased to use Fluence's Aspiral(TM) smart packaged solution, which is based on their proven MABR technology. We anticipate that our cooperation with Fluence will lead to a compelling new solution for wastewater treatment at highway service areas in Hubei Province."

Fluence Managing Director and CEO Henry Charrabé added: "We're pleased to be working with Hubei ITEST to expand Aspiral's reach in Hubei Province. The advantages of MABR are especially evident in applications like this, where space is scarce, noise and odour need to be managed, and Class 1A effluent is required. We see large potential for future expansion with Hubei ITEST for similar applications along the many highways in Hubei Province."

To view figures, please visit:
http://abnnewswire.net/lnk/9WQFA4S9


About Fluence Corporation Ltd

Fluence Corporation (ASX:FLC) (OTCMKTS:EMFGF) is a leader in the decentralized water, wastewater and reuse treatment markets, with its Smart Products Solutions, including Aspiral, NIROBOX, NIROFLEX and SUBRE. Fluence offers an integrated range of services across the complete water cycle, from early stage evaluation, through design and delivery to ongoing support and optimization of water related assets, as well as Build Own Operate Transfer (BOOT) and other recurring revenue solutions. With established operations in North America, South America, the Middle East, Europe and China, Fluence has experience operating in over 70 countries worldwide and enables businesses and communities worldwide to maximize their water resources.

Further information can be found at http://www.fluencecorp.com/

    

Contact

Corporate:
Henry Charrabé (USA)
Managing Director & CEO
E: hcharrabe@fluencecorp.com
P: +1-212-572-3766

Richard Irving (USA)
Executive Chairman
E: rirving@fluencecorp.com
P: +1-408-382-9790

Ross Kennedy (Australia)
Company Secretary & Advisor to the Board
E: rkennedy@fluencecorp.com
P: +61-409-524-442

Investors (Australia):
Ronn Bechler
Market Eye
E: ronn.bechler@marketeye.com.au
P: +61-400-009-774

Media (Australia):
Tristan Everett
Market Eye
E: tristan.everett@marketeye.com.au
P: +61-403-789-096

Investors & media (USA):
Gary Dvorchak, CFA
The Blueshirt Group
E: gary@blueshirtgroup.com
P: +1-323-240-5796 (US) or +86-138-1079-1480 (China)



Link: Aspiral sales expand in Hubei China with new partner


Related Companies

Fluence Corporation Ltd
       


Related Industry Topics:

 (21589)